A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes

Clinical trial NCT07712562 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07712562
Sponsor: Dren Bio
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bone Marrow Failure Syndromes Aplastic Anemias Severe Aplastic Anemia (SAA)Severe Aplastic Anemia, Relapse Severe Aplastic Anemia, Refractory Non-severe Aplastic Anemia

Start date: 2026-08-01
Primary completion: 2029-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.